Atlas Trials

Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)

Clinical trial NCT02101957 · UNKNOWN

Trial details

NCT number
NCT02101957
Sponsor
University Hospital, Angers
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Huntington's Disease
Start date
2010-10-01
Primary completion
2015-07-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.